January 2019 – Page 2 – Boston Harbor Angels

16JanJanuary 16, 2019

Local company developing EpiPen alternative that would last longer

Those who rely on lifesaving injectable epinephrine pens, known by the brand name EpiPens, know the expensive often go unused and expire. Now, a local company is developing an innovative injector that patients can hang on to longer that could also save them money. Read more >>

Portfolio NewsWindgap Medical

16JanJanuary 16, 2019

Seeing clearly now

Man receives new lease on life with eSight eyewear. Read more >>

Portfolio NewseSight

12JanJanuary 12, 2019

Student Choice partners with FutureFuel.io to bring highly desired student loan repayment benefits to credit unions

Credit Union Student Choice, the leading provider of higher education financing solutions to America’s credit unions, announced that is has partnered with FutureFuel.io to bring student loan repayment benefits to the credit union space. Read more >>

Portfolio NewsFutureFuel.io

12JanJanuary 12, 2019

FutureFuel.io Releases Student Debt FinHealth Platform Strategy and Adds Partners to Scale Student Debt-Centric Benefits Nationwide

FutureFuel.io announced the release of its broader Student Debt FinHealth platform, as well as partnerships with multiple channel partners that accelerate the company’s mission to crush student debt across the nation. Read more >>

Portfolio NewsFutureFuel.io

11JanJanuary 11, 2019

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. Read more >>

Portfolio NewsRevBio

09JanJanuary 9, 2019

Dan Feinberg: A CES 2019 Preview

The Saturday before CES begins is a transition day here in Las Vegas. The weekend sports fans and partygoers are leaving, and floods of techies from around the world are pouring in. This afternoon, a number of the very first 2019 public relation gatherings—showing mostly startup companies—are open to the press. Read more >>

Portfolio NewseSight

09JanJanuary 9, 2019

All Hands on Tech – eSight electronic assisted glasses enhance eyesight

Toronto-based eSight has been making its device that helps legally-blind people see, using a visor that relays an enhanced camera image to two screens right in front of the eyes. Read more >>

Portfolio NewseSight

07JanJanuary 7, 2019

eSight reduces electronic glasses price by 40 per cent

eSight, the makers of the eSight electronic glasses, is permanently dropping the pricing of its eSight glasses from $10,000 USD to $5,950 USD starting today. Read more >>

Portfolio NewseSight

06JanJanuary 6, 2019

Toy-Sharing Subscriptions Are Gaining In Popularity

Green Piñata Toys focuses on younger children (up to age 5.) With hundreds of toys, including wooden blocks, puzzles, shape sorters and more classic choices, your baby or preschooler can have hours of fun with up to four new toys each month in the subscription box. Green Piñata Toys has a set price of $24.99 and shipping is free. Read more >>

Portfolio NewsGreen Piñata Toys

04JanJanuary 4, 2019

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd. ("Kaken") for the development and commercialization in Japan of Corbus' investigational drug lenabasum for the treatment of systemic sclerosis ("SSc") and dermatomyositis ("DM"), two rare and serious autoimmune diseases. Read more >>

Portfolio NewsCorbus Pharmaceuticals

Monthly Archives - January 2019